Effect of Common Medications on Breast Cancer-Related Lymphedema

NOTE: The article for this course is available through the Rehabilitation Oncology (RO) site; or in the Resources area of this course.

Course Description:

The purpose of this course is to provide clinicians with a greater understanding of the impact of common medications on breast cancer-related lymphedema.

Primary Author bio:

Emily Tesar, MSN, RN, OCN is an experienced oncology nurse and nurse educator. She has practiced in a variety of nursing settings, including as an oncology nurse patient navigator and regional care navigator in Montana. She holds a Masters of Science in Nursing and completed this review as part of her doctoral studies at University of Missouri.

Dr. Jane Armer is Professor, University of Missouri Sinclair School of Nursing, and founding Director, American Lymphedema Framework Project, a national organization housed at University of Missouri which aims to increase awareness of lymphedema and improve care for persons with lymphedema in the US and around the world. She focuses her research on the more-than-3-million breast cancer survivors who are at risk for lymphedema. She has conducted extensive work in lymphedema incidence and prevalence; signs and symptoms; fatigue; and self-management of chronic illness. She has expertise in anthropometric measurements and lymphedema management.

Course Code:

LMS-986-6

APTACategory

Category1

cert_CA approval

CPTA2018-19

cert_Insert Up To

No

cert_Logo One

cert_No IACET

No

cert_NV credit value

0.2

cert_NY approval

Yes

cert_Transcript stmt

No

cert_TX approval

1909019TX

Completion Instructions

Read the article, complete the assessment with at least a 70% score, claim your certificate

Course level

Intermediate

Date published

09/14/2018

Delivery method

Text

Instructor(s)

Tesar, E., & Armer, J. M.

Learning objectives

Upon completion of this OncoRead course, the learner will be able to:

  1. Describe the EDGE task force systematic review process to evaluate and recommend clinical measures for pain in patients with cancer.
  2. Describe important criteria for evaluating and selecting clinical measures of pain for use in clinical practice.
  3. Utilize the EDGE task force recommendations to select measures of pain in an oncology practice setting.
  4. Describe the psychometric properties for recommended clinical measures of pain.

Partner(s)

Academy of Oncologic Physical Therapy

Brought to you by

APTA

#Lessons:
1PDF
2Assessment_OncoReads_Breast Cancer
Overview
Type:E-Learning Course
Credits:0.2
Credit Categories
Domains:tesar, Oncology, lymphedema, cancer
Enrollment
Price:$90.00
Available discounts:
  • Non Member
    $90.00
    (until 12/31/2030)
  • Member
    $54.00
    (until 12/31/2030)
  • Oncology
    $48.60
    (until 12/31/2030)
* Prices in US Dollar